[Federal Register Volume 82, Number 98 (Tuesday, May 23, 2017)]
[Notices]
[Pages 23578-23581]
[FR Doc No: 2017-10537]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-D-0349]

Agency Information Collection Activities; Proposed Collection;
Comment Request; Providing Waiver-Related Materials in Accordance With
the Guidance for Industry on Providing Post-Market Periodic Safety
Reports in the International Conference on Harmonisation E2C(R2) Format

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(PRA), Federal Agencies are required to publish notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information, and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on the collection of information associated
with the Guidance ``Providing Post-market Periodic Safety Reports in
the ICH E2C(R2) Format (Periodic Benefit-Risk Evaluation Report).''

DATES: Submit either electronic or written comments on the collection
of information by July 24, 2017. Late, untimely filed comments will not
be considered. Electronic comments must be submitted on or before July
24, 2017. The https://www.regulations.gov electronic filing system will
accept comments until midnight Eastern Time at the end of July 24,
2017. Comments received by mail/hand delivery/courier (for written/
paper submissions) will be considered timely if they are postmarked or
the delivery service acceptance receipt is on or before that date.

ADDRESSES: You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you

do not wish to be made available to the public, submit the comment as a
written/paper submission and in the manner detailed (see ``Written/
Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Division of
Dockets Management, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2013-D-0349 for ``Providing Waiver-Related Materials in Accordance
With the Guidance for Industry on Providing Post-market Periodic Safety
Reports in the International Conference on Harmonisation E2C(R2)
Format.'' Received comments, those filed in a timely manner (see
DATES), will be placed in the docket and, except for those submitted as
``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Division of Dockets Management between 9
a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Division of Dockets Management. If you do not
wish your name and contact information to be made publicly available,
you can provide this information on the cover sheet and not in the body
of your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A63, 11601
Landsdown St., North Bethesda, MD 20852,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

Providing Waiver-Related Materials in Accordance With the Guidance for
Industry on Providing Post-Market Periodic Safety Reports in the
International Conference on Harmonisation E2C(R2) Format (Periodic
Benefit-Risk Evaluation Report), OMB Control Number 0910-0771--
Extension

    The International Conference on Harmonisation (ICH) of Technical
Requirements for Registration of Pharmaceuticals for Human Use issued,
on November 15, 2012, the ICH harmonized tripartite guideline entitled
``Periodic Benefit-Risk Evaluation Report (PBRER) E2C(R2)'' (the PBRER
guideline) (available at http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html). The PBRER guideline is
intended to promote a consistent approach to periodic post-marketing
safety reporting among the ICH regions and to enhance efficiency by
reducing the number of reports generated for submission to the
regulatory authorities. The PBRER is intended to provide a common
standard for periodic reporting on approved drugs or biologics among
the ICH regions.
    FDA currently has OMB approval for the required submission of
periodic adverse drug experience reports (PADER) for drugs subject to a
new drug application (NDA) or an abbreviated new drug application
(ANDA) (Sec.  [thinsp]314.80(c)(2) (21 CFR 314.80(c)(2)) (OMB control
number 0910-0230), and for the required submission of periodic adverse
experience reports (PAER) for drugs subject to a biologics license
application (BLA) (Sec.  [thinsp]600.80(c)(2) (21 CFR 600.80(c)(2))
(OMB control number 0910-0308).
    There is considerable overlap in the information required under
Sec. Sec.  [thinsp]314.80(c)(2) and 600.80(c)(2) and the information
requested in a periodic safety report using the ICH E2C(R2) PBRER
format. Applicants subject to periodic safety reporting requirements
under FDA regulations could choose to continue to submit the reports as
specified in those regulations, and would be permitted to submit
reports in the PBRER format and submit reports as specified in FDA
regulations with an approved waiver. Companies who submit periodic
reports on the same drug to multiple regulators, including not only the
United States, but, also the European Union, Japan, and regulators in
other countries who have elected to adopt the ICH standards, may find
it in their interest to prepare a single PBRER,

rather than preparing multiple types of reports for multiple
regulators. As a result, FDA, in the Federal Register of November 29,
2016 (81 FR 85976), announced the availability of the guidance for
industry entitled ``Providing Post-marketing Periodic Safety Reports in
the ICH E2C(R2) Format (Periodic Benefit-Risk Evaluation Report)'' to
indicate its willingness to accept post-market periodic safety reports
using the ICH PBRER format in lieu of the specific reports described in
FDA regulations.
    Because FDA regulations in Sec. Sec.  [thinsp]314.80(c)(2) and
600.80(c)(2) include specific requirements for periodic safety reports,
in order for an applicant to submit an alternative report, such as the
PBRER, for a given product, FDA must grant a waiver. Existing
regulations permit applicants to request waivers of any post-marketing
safety reporting requirement, and the information collections
associated with such waiver requests generally are approved under
existing control numbers. (See Sec.  [thinsp]314.90(a), waivers for
drugs subject to NDAs and ANDAs, approved under OMB control number
0910-0001, and Sec.  [thinsp]600.90(a), waivers for products subject to
BLAs, approved under OMB control number 0910-0308.) The November 29,
2016, guidance both explains conditions under which applicants that
have previously received waivers to submit reporting information in the
format of the previous ICH guidance would be permitted to apply those
existing waivers to the submission of PBRERs, and also advises how
applicants that have not previously obtained a waiver may submit waiver
requests to submit the PBRER.
    There are information collections proposed in the November 29,
2016, guidance that are related to waivers specifically to enable the
submission of PBRERs, and these information collections are not already
addressed under the approved control numbers covering waiver
submissions and periodic safety reports generally. FDA has previously
granted waiver requests, submitted under Sec. Sec.  [thinsp]314.90(a)
and 600.90(a), that allow applicants to prepare and submit reports
using the periodic safety update report (PSUR) format described in
FDA's 1996 and 2004 ICH E2C guidance. In accordance with the
recommendations of the November 29, 2016, guidance, if an applicant
already has a PSUR waiver in place for a given approved application,
FDA will consider the existing PSUR waiver to allow the applicant to
submit a PBRER instead of a PSUR because the PBRER replaces the PSUR
for post-marketing periodic safety reporting for that application. The
applicant would not need to submit a new waiver request unless the
applicant wishes to change the frequency of reporting. FDA will
consider requests to be waived of the quarterly reporting requirement
but will not waive applicants of the annual reporting requirement.
    If an applicant submits a PBRER in place of the PSUR and uses a
different data lock point, the applicant should submit overlapping
reports or submit a one-time PADER/PAER in order to cover the gap in
reporting intervals. The applicant should submit notification to the
application(s), indicating the change in data lock point and should
include a description of the measures taken to ensure that there are no
resulting gaps in reporting.
    If an applicant submits a PBRER in place of the PSUR and uses a
different reporting frequency for the PBRER than was used for the PSUR,
the continued validity of the waiver will be conditioned on the
submission of a PADER/PAER as needed to fulfill the reporting frequency
requirement under FDA regulations. The applicant should submit a
notification to the application(s), describing this change and the
measures taken to ensure that the periodicity requirements are being
met.
    FDA expects approximately 187 waiver requests and notifications to
include the additional information described previously in this
document for using a different data lock point and/or for using a
different reporting frequency when submitting a PBRER. FDA expects
approximately 55 applicants to make these submissions, and we estimate
that the time for submitting the additional information described
previously would be on average approximately 1 hour for each waiver
request or notification.
    If an applicant does not have a PSUR waiver in place for an
approved application, the applicant may submit a waiver request under
Sec.  [thinsp]314.90(a) or Sec.  [thinsp]600.90(a) to submit a PBRER
instead of the PADER/PAER. The applicant should submit a request to FDA
for each approved application for which a waiver is requested, and a
single waiver request letter can include multiple applications. Waiver
requests should be submitted to each of the application(s) in the
request, and may be submitted electronically or by mail as described in
the November 29, 2016, guidance. Each PBRER waiver request should
include the following information:
     The product name(s) and application number(s);
     a brief description of the justification for the request;
     the U.S. approval date for the product(s) and current
reporting interval used;
     the reporting interval of the last PADER/PAER submitted
for the product(s); and
     the data lock point that will be used for each PBRER. If a
data lock point other than one aligned to the U.S. approval date is
proposed, the applicant should describe how he/she will ensure that
there are no gaps in reporting intervals (e.g., by submitting
overlapping reports; submitting a one-time PADER/PAER to cover the gap
period; or, if the gap is less than 2 months, extending the reporting
interval of the final PADER/PAER to close the gap).
     The frequency for submitting the PBRER, as described in
section IV.C of the April 8, 2013, draft guidance.
     The email address and telephone number for the individual
who can provide additional information regarding the waiver request.
    As explained earlier, existing regulations at Sec.  314.90(a) or
600.90(a) permit applicants to request waivers of any post-marketing
safety reporting requirement, and the information collections
associated with such waiver requests generally are approved under OMB
control numbers 0910-0001 and 0910-0308. FDA believes that the
information submitted under numbers 1-4 and number 7 in the list in the
previous paragraph is information that is typical of any waiver request
regarding post-marketing safety reporting and is accounted for in the
existing approved collections of information for waiver requests and
reports. Concerning numbers 5 and 6, FDA expects approximately 67
waiver requests to include the additional information for using a
different data lock point and/or for using a different reporting
frequency when submitting a PBRER. FDA expects approximately 29
applicants to make these submissions, and we estimate that the time for
submitting the additional information described in the previous
paragraph would be on average approximately 2 hours for each waiver
request.
    FDA estimates the additional burden of this collection of
information as follows:

                                     Table 1--Estimated Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
  Additional information and/or
    notifications for using a        Number of       Number of     Total annual       Average
different data lock point and/or    respondents    responses per     responses      burden per      Total hours
a different reporting  frequency                    respondent                       response
----------------------------------------------------------------------------------------------------------------
Applicants that have a PSUR                   55             3.4             187               1             187
 waiver for an approved
 application....................
Applicants that do not have a                 29             2.3              67               2             134
 PSUR waiver for an approved
 application....................
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............             321
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital or operating and maintenance costs associated with the information collection.

    Dated: May 18, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-10537 Filed 5-22-17; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register: September 2, 2010 (Volume 75, Number 170)]
[Notices]
[Page 53976-53977]
[DOCID:fr02se10-73]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0449]

Risks and Benefits of Long-Term Use of Nicotine Replacement
Therapy Products; Public Workshop; Request for Comments

AGENCY: Food and Drug Administration, HHS.

ACTION:  Notice of public workshop; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA), Center for Drug
Evaluation and Research (CDER) is announcing a scientific workshop to
solicit feedback on the risks and benefits associated with the long-
term use of nicotine replacement therapy (NRT) products. NRT products
facilitate smoking cessation by ameliorating the symptoms of nicotine
withdrawal and are available as approved nonprescription and
prescription drugs. No currently-approved NRT product is intended for
use beyond 12 weeks to relieve the acute withdrawal symptoms
experienced when quitting smoking.
    Date and Time: The public workshop will be held on October 26 and
27, 2010, from 8:30 a.m. to 5 p.m.
    Location: The workshop will be held at the Radisson Hotel, Reagan
National Airport, 2020 Jefferson Davis Highway, Arlington, VA 22202,
703-920-8600, FAX:<PHONE_NUMBER>.
    Contacts: Mary C. Gross, Center for Drug Evaluation and Research,
Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, rm.
6178, Silver Spring, MD 20993-0002,<PHONE_NUMBER>, email:
<EMAIL_ADDRESS>or Dominic Chiapperino, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, rm. 3134, Silver Spring, MD 20993-0002, 301-
796-1183, email<EMAIL_ADDRESS>    Registration to Attend the Workshop and Requests to Participate in
Open Public Hearing: If you wish to attend or testify for the open
public hearing, please email your registration to
<EMAIL_ADDRESS>by October 5, 2010. Those without email
access may register by contacting one of the persons listed in the
Contacts section of the document. Please provide complete contact
information for each attendee, including name, title, affiliation,
address, email address, and telephone number. Registration is free and
will be on a first-come, first-served basis. Early registration is
recommended because seating is limited. FDA may limit the number of
participants from each organization as well as the total number of
participants based on space limitations. Registrants will receive
confirmation once they have been accepted for the workshop. Onsite
registration on the day of the meeting will be based on space
availability. If registration reaches maximum capacity, FDA will post a
notice closing meeting registration for the workshop at: http://
www.fda.gov/Drugs/NewsEvents/ucm221185.htm.
    An open public hearing will be held between 1:30 p.m. to 2:30 p.m.
on October 27, 2010, during which speaker testimony will be accepted.
We will try to accommodate all persons who wish to testify, however,
the duration of each

speaker's testimony during this open public hearing may be limited by
time constraints.
    Comments: Submit either electronic or written comments by December
27, 2010. Submit electronic comments to http://www.regulations.gov.
Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. It is only necessary to send one set of comments.
It is no longer necessary to send two copies of mailed comments.
Identify comments with the docket number found in brackets in the
heading of this document. Received comments may be seen in the Division
of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.
    If you need special accommodations due to a disability, contact
Mary Gross or Dominic Chiapperino (see Contacts) at least 7 days in
advance.

SUPPLEMENTARY INFORMATION:

I. Introduction

    Nicotine is the primary addictive substance in tobacco. NRT
products are designed to help people stop smoking by supplying
controlled amounts of purified nicotine to replace the nicotine derived
from smoking. People who use NRT products instead of cigarettes during
an attempt to quit smoking obtain nicotine to ease the symptoms
associated with quitting, but significantly reduce their exposure to
harmful chemicals present in tobacco products and tobacco smoke. NRT
products are available over-the-counter (OTC) and by prescription. The
labeling for all NRT products recommends that they be used for a short
time only (up to 12 weeks) to relieve the acute withdrawal symptoms
experienced when quitting smoking. Prescription NRT products are
marketed under the brand name Nicotrol and are available as a nasal
spray and oral inhaler. OTC NRT products include skin patches
(transdermal nicotine patches, various brand names and generics),
chewing gum (Nicorette and generics) and lozenges (Commit, Nicorette,
and generics).
    FDA will explore the following topics during this public workshop:
     What is known about the long-term safety of nicotine from
animal studies?
     What is known about the long-term safety of nicotine from
human studies?
     What evidence is there that long-term NRT helps people to
sustain abstinence from smoking?
     What evidence is there that long-term NRT helps people to
sustain reduced smoking levels?
     What evidence is there that using NRT to maintain reduced
levels of smoking, rather than complete abstinence, yields clinical
benefits?
     What is known about dependence/addiction to NRT products?
     Does the route of administration/speed of onset influence
the addiction potential?
     What factors mitigate against abuse/addiction to NRT
products and against initiation of NRT products by people who have
never used tobacco products previously?
    FDA will post the agenda and additional workshop background
material approximately 5 days before the workshop at: http://
www.fda.gov/Drugs/NewsEvents/ucm221185.htm.

II. Transcripts

    Please be advised that approximately 30 days after the public
workshop, a transcript will be available. It will be accessible at
http://www.regulations.gov, and may be viewed at the Division of
Dockets Management (see Comments). A transcript will also be available
in either hardcopy or on CD-ROM, after submission of a Freedom of
Information request. Written requests are to be sent to Division of
Freedom of Information (HFI-35), Office of Management Programs, Food
and Drug Administration, 5600 Fishers Lane, rm. 6-30, Rockville, MD
20857.

    Dated: August 27, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
[FR Doc. 2010-21894 Filed 9-1-10; 8:45 am]
BILLING CODE 4160-01-S


From:
Brenna M Harden<EMAIL_ADDRESS>Sent:
Tue, 16 Aug 2022 16:04:32
To:
"Jones; DonnaLee"<EMAIL_ADDRESS>"French; Chuck"<EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS>Subject:
Coke Oven Section 114 ICR Enclosure 2 - Fugitive Monitoring Plan, Test Plan and QAPP

On June 29, 2022, DTE Vantage (DTE) received Section 114 of the Clean Air Act Information Collection Request (ICR) in relation to development of Risk and Technology Review of Coke Oven Facilities related to 40 CFR Part 63, Subpart CCCCC, Pushing Quenching and Battery Stacks. The ICR also included risk and technology review, testing, interior and fenceline monitoring, and other information collection activities related to potential new regulations for coke byproduct recovery plants (CBRP) in relation to 40 CFR Part 63, Subpart L, Coke Oven Batteries. DTE owns and operates EES Coke Battery, L.L.C. (EES Coke) located in River Rouge, MI.

In order to accommodate all Enclosure 2 Source Testing, there are four enclosures. EES Coke was required to complete Testing on Fugitive and Flares. The enclosures meet the Fugitive Monitoring Plan, Test Plan and QAPP task. Although the June 28, 2022 ICR noted this task was due within 45 days of the submission (August 13, 2022), the COETF requested an extension during the August 9 virtual meeting. EPA provided an email on August 11, 2022 granting the extension to August 16, 2022.

Due to size of this submittal, can you let me know that you received it? I may break up the submittal into several emails if it gets trapped due to size. A hard copy will also be submitted certified mail  -  return receipt requested as backup.

Regards,
Brenna Harden
DTE Vantage | EES Coke Battery, L.L.C., Senior Environmental Engineer
PO Box 18309, River Rouge, MI 48218o<PHONE_NUMBER> | m<PHONE_NUMBER>
dtevantage.com

<<EES Submission EPA ICR Enclosure 2 QAPP 08162022 signed.pdf>>
<<EES Coke ICR_Fugitive QAPP_R0b_FINAL_081622b signed.pdf>>
<<EES Coke ICR QAPP Flares rev1 08162022.pdf>>
<<ICR Test Plan EES Coke Em Bleeder Stack 08162022 signed.pdf>>
<<ICR Test Plan EES Coke BP Flare 08162022 signed.pdf>>


DATE:	April 2, 2017

SUBJECT:	Technology Review for the Friction Materials Manufacturing Facilities Source Category  -  Proposed Rule

FROM:	Korbin Smith, Environmental Protection Agency
	David Bullock, RTI International

TO:	Docket EPA-HQ-OAR-2017-0358

I.	BACKGROUND
Requirements of Section 112(d)(6) of the CAA
Section 112 of the Clean Air Act (CAA) requires the EPA to establish technology-based standards for sources of HAP. These technology-based standards are often referred to as maximum achievable control technology, or MACT, standards. Section 112 also contains provisions requiring the EPA to periodically review these standards. Specifically, paragraph 112(d)(6) states:
      (6) REVIEW AND REVISION.  -  The Administrator shall review, and revise as necessary (taking into account developments in practices, processes, and control technologies), emissions standards promulgated under this section no less often than every 8 years.

Description of the Friction Materials Manufacturing Facilities Source Category and Requirements of the Current NESHAP
The current National Emissions Standards for Hazardous Air Pollutants (NESHAP) for the Friction Materials Manufacturing Facilities source category were promulgated on October 18, 2002 (67 FR 64506) as 40 CFR part 63, subpart QQQQQ.[1] The NESHAP applies to affected sources of HAP at friction materials manufacturing facilities that are major sources of HAP. A friction materials manufacturing facility is defined as a facility that manufactures friction materials using a solvent-based process. The affected source covered by this subpart is each new, reconstructed, or existing solvent mixer at a friction materials manufacturing facility.
A solvent mixer is defined as a mixer used in the friction materials manufacturing process in which HAP solvent is used as one of the ingredients in at least one batch during a semiannual reporting period. Emission limits were promulgated for HAP solvents. A HAP solvent is defined as a solvent that contains 10 percent or more of any one HAP, as listed in section 112(b) of the CAA, or any combination of HAP that is added to a solvent mixer. HAP solvents are emitted from the solvent mixer and from downstream processes (e.g., hot presses, post bake ovens, saturators, and dryers).
We identified two friction materials manufacturing facilities that are subject to the NESHAP. Control devices currently in use at these two facilities to reduce HAP emissions from affected sources include a solvent recovery (condenser) system and a permanent total enclosure with an incinerator.
II.	DEVELOPMENTS IN PRACTICES, PROCESSES, AND CONTROL TECHNOLOGIES
For the purposes of this technology review, a "development" was considered to be a(n):
 Any add-on control technology or other equipment that was not identified and considered during development of the original MACT standards;
 Any improvements in practices, processes, or add-on control technology (that were identified and considered during development of the original MACT standards) that could result in significant additional emissions reduction;
 Any work practice or operational procedure that was not identified or considered during development of the original MACT standards;
 Any process change or pollution prevention alternative that could be broadly applied to the industry and that was not identified or considered during development of the original MACT standards;
 Any significant changes in the cost (including cost-effectiveness) of applying controls (including controls the EPA considered during the development of the original MACT standards).

We investigated developments in practices, processes, and control technologies through discussions with industry representatives, and included questions related to the technology review in the site visit request letters that were sent to both companies thought to be subject to the NESHAP. We also conducted a review of EPA's Technology Transfer Network (TTN) Clean Air Technology Center  -  RACT/BACT/LAER Clearinghouse (RBLC) database. The results of these analyses are presented in the following sections.
 Permanent Total Enclosure and Incinerator (PTEI)
One facility controls HAP emissions from the solvent mixer by capturing HAP emissions with a permanent total enclosure and routing the emissions to a boiler/incinerator for destruction. The specific capture and control system installed at this friction materials manufacturing facility was constructed in 2002, and therefore did not exist at proposal, and was not identified prior to promulgation of the current NESHAP in October 2002.
Emission control systems including a permanent total enclosure and incinerator are already accommodated under the provisions for alternative compliance requirements at §63.9570. Emissions testing showed the destruction efficiency for HAP was >99%. Therefore, the overall control efficiency (i.e., the product of capture efficiency and HAP destruction efficiency) is >99%, which exceeds the overall control efficiency of 70% reduction criteria of 40 CFR §63.9500(a).
Using the most recent EPA Air Pollution Control Cost Manual.[2] A cost estimation was calculated for installing a PTEI in the remaining major source facility not using this technology. To remain consistent throughout the cost estimate, mean values were used when ranges were available. For additional information on the calculated costs see the memo "Permanent Total Enclosure and Incinerator Cost Memo" in docket: EPA-HQ-OAR-2017-0358. The total capital investment (TCI) would be $1,660,627, and the total annual cost would be $848,155.
The installation of a PTEI at the remaining major source facility was calculated to reduce the amount of HAP emitted by 228 tons (using a destruction efficiency of 98%). This results in cost per ton of HAP emissions reduction of $3,720 based on this analysis.
 This is a development in practices, processes, or control technologies for the friction materials manufacturing source category under section 112(d)(6), and may be included among technologies achieving emission reductions in the NESHAP.
 Non-Solvent Process and Product Reformulation
One facility is currently in the process of converting their friction material production from a HAP solvent, to a non-HAP solvent process. This process change reformulates the product recipes to allow the use of a non-solvent mixer. Using a non-solvent mixer eliminates the use of HAP solvents and their associated emissions.
The above facility provided information on the total capital investment for purchasing and installing the non-solvent mixer. The mixer and downstream material processing equipment's estimated total capital investment was $2,073,430. Annual cost of operation is approximately $125,000 for electrical cost, and $75,000 for maintenance. Due to the remaining facility already achieving >99% destruction efficiency, a detailed cost analysis was not deemed necessary, as the cost per ton of HAP reduction would be excessive.
Opportunities for process changes to reduce HAP emissions from friction materials manufacturing can vary widely and are influenced by the specific product being manufactured and the required product performance specifications. Therefore, a specific process change that may be used successfully to reduce HAP emissions at one facility may not work for another facility.
Although the use of a non-solvent mixer is not specifically identified in the current NESHAP, process changes such as converting to a process that does not require the use of HAP solvents are accommodated via the solvent substitution provisions of the rule. In fact, the solvent substitution provisions were included to encourage these types of process changes.
This process change was not specifically identified in the current NESHAP, thus is considered to be a new development in practices, processes, or control technologies for the Friction Materials Manufacturing source category under section 112(d)(6), and could be used to update the technology in the NESHAP.
RACT/BACT/LAER Clearinghouse Search
Under EPA's "New Source Review" (NSR) program, if a company is planning to build a new plant or modify an existing plant such that air pollution emissions will increase by a large amount, then the company must obtain an NSR permit. The NSR permit is a construction permit which requires the company to minimize air pollution emissions by changing the process to prevent air pollution and/or installing air pollution control equipment.[3]
The terms "RACT," "BACT," and "LAER" are acronyms for different program requirements under the NSR program. RACT, or Reasonably Available Control Technology, is required on existing sources in areas that are not meeting national ambient air quality standards (i.e., non-attainment areas). BACT, or Best Available Control Technology, is required on major new or modified sources in clean areas (i.e., attainment areas). LAER, or Lowest Achievable Emission Rate, is required on major new or modified sources in non-attainment areas. BACT and LAER (and sometimes RACT) are determined on a case-by-case basis, usually by State or local permitting agencies.[3]
The EPA established the RACT/BACT/LAER Clearinghouse, or RBLC, to provide a central data base of air pollution technology information (including past RACT, BACT, and LAER decisions contained in NSR permits) to promote the sharing of information among permitting agencies and to aid in future case-by-case determinations. However, data in the RBLC are not limited to sources subject to RACT, BACT, and LAER requirements. Noteworthy prevention and control technology decisions and information are included even if they are not related to past RACT, BACT, or LAER decisions.[3]
The RBLC permit data base contains over 5,000 determinations that can help you identify appropriate technologies to mitigate most air pollutant emission streams. The RBLC permit data base was designed to help permit applicants and reviewers make pollution prevention and control technology decisions for stationary air pollution sources, and includes data submitted by several U.S. territories and all 50 States on over 200 different air pollutants and 1,000 industrial processes.[3]
The RBLC provides several options for searching the permit database on-line to locate applicable control technologies. Searches of the RBLC database were conducted in January 2017. The permit dates for the searches used the NESHAP part 63 subpart QQQQQ proposal date (October 4, 2001) through December 31, 2016.
There is no specific "process type" code in the RBLC for friction materials manufacturing, therefore we searched for process names containing relevant key words. The search for process names including the term "friction" yielded no results. The search for process names including the term "mix" (intended to identify determinations for solvent mixers) yielded 32 facilities and 40 processes with determinations during the period 2001  -  2016. Most of the identified facilities fall into three general industry types: iron and steel, tire and rubber, and petroleum. None of the identified processes were solvent mixers (or similar), therefore none of these determinations are relevant to QQQQQ.
The search for process names including the term "solvent" (intended to identify determinations for solvent recovery systems) yielded 26 facilities and 27 processes with determinations during the period 2001  -  2016. Most of the identified facilities fall into three general industry types: automotive, chemical, and food and agriculture (e.g., oil seed processing). The search results included no friction materials manufacturing facilities, no solvent mixers, and no determinations for HAP solvents from similar processes. Although the search identified no directly comparable manufacturing processes and no relevant determinations for HAP solvents, the VOC control determinations for the identified processes included condensers, absorbers, combustion (e.g., thermal oxidizer, boiler, flare), and pollution prevention techniques (e.g., work practices, operating practices, or design practices). These emission reduction alternatives were identified at proposal of the NESHAP or (in the case of combustion controls) during information collection efforts for the technology review for QQQQQ.
There is no new information from the RBLC search for the technology review.

References

       National Emission Standards for Hazardous Air Pollutants for Friction Materials Manufacturing Facilities. See Federal Register Notice 67FR64506, dated October 18, 2002.
       United States Environmental Protection Agency. (2002, January). EPA Air Pollution Control Cost Manual Sixth Edition. Retrieved from https://www3.epa.gov/ttn/ecas/docs/c_allchs.pdf
       U.S. EPA. RACT/BACT/LAER Clearinghouse. Available at: https://www3.epa.gov/ttn/catc/rblc/htm/welcome_eg.html


[Federal Register: February 5, 2008 (Volume 73, Number 24)]
[Rules and Regulations]
[Page 6584-6586]
[DOCID:fr05fe08-5]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2008-0100; Directorate Identifier 2007-SW-41-AD;
Amendment 39-15356; AD 2008-03-07]
RIN 2120-AA64

Airworthiness Directives; Eurocopter Model AS 332 L2 Helicopters

AGENCY: Federal Aviation Administration (FAA), Department of
Transportation (DOT).

ACTION: Final rule; request for comments.

-----------------------------------------------------------------------

SUMMARY: We are adopting a new airworthiness directive (AD) for
Eurocopter Model AS 332 L2 helicopters. This AD results from mandatory
continuing airworthiness information (MCAI) originated by an aviation
authority to identify and correct an unsafe condition on an aviation
product. The European Aviation Safety Agency (EASA), the Technical
Agent of France, with which we have a bilateral agreement, states in
the MCAI:

    A borescope inspection during scheduled maintenance revealed
wear on the internal skin of a Life Raft Inflation Cylinder, P/N
41918001, that had been installed on a Eurocopter AS 332 L2
helicopter. The plunger tube end is fitted with a metal end-fitting
that presses against the internal surface of the cylinder due to its
installation horizontally aboard the aircraft. Vibrations generated
by helicopter operation are therefore causing such wear, which may
result in a drop of internal pressure of the cylinder. This internal
damage, if not corrected, could lead to functional failure of the
cylinder, making the life raft inflation no longer possible.

This AD requires actions that are intended to address the failure of a
life raft to inflate during an emergency landing on water (ditching),
which could result in loss of the crew and passengers.

DATES: This AD becomes effective on February 20, 2008.
    The Director of the Federal Register approved the incorporation by
reference of Eurocopter Alert Service Bulletin No. 05.00.71, dated July
31, 2007, as of February 20, 2008.
    We must receive comments on this AD by April 7, 2008.

ADDRESSES: You may send comments by any of the following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov.
 Follow the instructions for submitting comments.

     Fax:<PHONE_NUMBER>.

     Mail: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue, SE., Washington, DC 20590.
     Hand Delivery: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue, SE., Washington, DC 20590, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal holidays.
    Examining the AD Docket: You may examine the AD docket on the
Internet at http://www.regulations.gov or in person at the Docket

Operations office between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The AD docket contains this AD, the economic
evaluation, any comments received, and other information. The street
address for the Docket Operations office (telephone<PHONE_NUMBER>) is
in the ADDRESSES section. Comments will be available in the AD docket
shortly after receipt.

FOR FURTHER INFORMATION CONTACT: Uday Garadi, Aviation Safety Engineer,
FAA, Rotorcraft Directorate, Regulations and Policy Group, Fort Worth,
Texas 76193-0110, telephone<PHONE_NUMBER>, fax<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Streamlined Issuance of AD

    The FAA is implementing a new process for streamlining the issuance
of ADs related to MCAI. This streamlined process will allow us to adopt
MCAI safety requirements in a more efficient manner and will reduce
safety risks to the public. This process continues to follow all FAA AD
issuance processes to meet legal, economic, Administrative Procedure
Act, and Federal Register requirements. We also continue to meet our
technical decision-making responsibilities to identify and correct
unsafe conditions on U.S.-certificated helicopters.
    This AD references the MCAI and related service information that we
considered in forming the engineering basis to correct the unsafe
condition. The AD contains text copied from the MCAI and for this
reason might not follow our plain language principles.

Discussion

    The European Aviation Safety Agency (EASA), which is the Technical
Agent for the Member States of the European Community, has issued EASA
AD No. 2007-0244, dated September 4, 2007 (referred to after this as
``the MCAI''), to correct an unsafe condition for the specified
helicopters. The MCAI states:

    A borescope inspection during scheduled maintenance revealed
wear on the internal skin of a Life Raft Inflation Cylinder, P/N
41918001, that had been installed on a Eurocopter AS 332 L2
helicopter. The plunger tube end is fitted with a metal end-fitting
that presses against the internal surface of the cylinder due to its
installation horizontally aboard the aircraft. Vibrations generated
by helicopter operation are therefore causing such wear, which may
result in a drop of internal pressure of the cylinder. This internal
damage, if not corrected, could lead to functional failure of the
cylinder, making the life raft inflation no longer possible.
    Pending the development of a modification to the inflation
cylinder, this AD requires identification of all affected cylinders
and the removal from service of those that have accumulated 2,500
Flight Hours (FH) or more since installation or since overhaul.

Relevant Service Information

    Eurocopter has issued Alert Service Bulletin No. 05.00.71, dated
July 31, 2007. The actions described in the MCAI are intended to
correct the same unsafe condition as that identified in the service
information.

FAA's Determination and Requirements of This AD

    This helicopter has been approved by the aviation authority of the
Member States of the European Community, and is approved for operation
in the United States. Pursuant to our bilateral agreement with this
State of Design Authority, we have been notified of the unsafe
condition described in the MCAI and the service information. We are
issuing this AD because we evaluated all pertinent information and
determined the unsafe condition exists and is likely to exist or
develop on other helicopters of the same type design.
    There are no helicopters of this type currently registered in the
United States. However, this rule is necessary to ensure that the
described unsafe condition is addressed if any of these products are
placed on the U.S. Registry in the future.

Differences Between the AD and the MCAI or Service Information

    We have reviewed the MCAI and related service information and, in
general, agree with their substance. We have limited the
``Applicability'' section of our AD to those helicopters type
certificated in the United States. We also changed ``flight hours'' to
``hours time-in-service.'' In making these small changes, we do not
intend to differ substantively from the information provided in the
MCAI and related service information. These differences are highlighted
in the ``Differences Between the FAA AD and the MCAI'' section in the
AD.

FAA's Determination of the Effective Date

    Since there are currently no domestic operators of these
helicopters, notice and opportunity for public comment before issuing
this AD are unnecessary, and this amendment can be made effective in
less than 30 days.

Comments Invited

    This AD is a final rule that involves requirements affecting flight
safety, and we did not precede it by notice and opportunity for public
comment. We invite you to send any written relevant data, views, or
arguments about this AD. Send your comments to an address listed under
the ADDRESSES section. Include ``Docket No. FAA-2008-0100; Directorate
Identifier 2007-SW-41-AD'' at the beginning of your comments. We
specifically invite comments on the overall regulatory, economic,
environmental, and energy aspects of this AD. We will consider all
comments received by the closing date and may amend this AD because of
those comments.
    We will post all comments we receive, without change, to http://www.regulations.gov
, including any personal information you provide. We

will also post a report summarizing each substantive verbal contact we
receive about this AD.

Costs of Compliance

    There are no costs of compliance since there are no helicopters of
this type design on the U.S. Registry.

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. ``Subtitle VII: Aviation
Programs,'' describes in more detail the scope of the Agency's
authority.
    We are issuing this rulemaking under the authority described in
``Subtitle VII, Part A, Subpart III, Section 44701: General
requirements.'' Under that section, Congress charges the FAA with
promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures the Administrator
finds necessary for safety in air commerce. This regulation is within
the scope of that authority because it addresses an unsafe condition
that is likely to exist or develop on products identified in this
rulemaking action.

Regulatory Findings

    We determined that this AD will not have federalism implications
under Executive Order 13132. This AD will not have a substantial direct
effect on the States, on the relationship between the national
government and the States, or on the distribution of power and
responsibilities among the various levels of government.
    For the reasons discussed above, I certify this AD:
    1. Is not a ``significant regulatory action'' under Executive Order
12866;
    2. Is not a ``significant rule'' under the DOT Regulatory Policies
and Procedures (44 FR 11034, February 26, 1979); and
    3. Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

Adoption of the Amendment

0
Accordingly, under the authority delegated to me by the Administrator,
the FAA amends 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority: 49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by adding the following new AD:

2008-03-07 Eurocopter: Amendment 39-15356. Docket No. FAA-2008-0100;
Directorate Identifier 2007-SW-41-AD.

Effective Date

    (a) This airworthiness directive (AD) becomes effective February
20, 2008.

Other Affected ADs

    (b) None.

Applicability

    (c) This AD applies to Eurocopter Model AS 332 L2, with Life
Raft, part number (P/N) 00051047 or P/N 00051048, that has a Life
Raft Inflation Cylinder, P/N 41918001, installed, certificated in
any category.

Reason

    (d) The mandatory continuing airworthiness information (MCAI)
states:
    A borescope inspection during scheduled maintenance revealed
wear on the internal skin of a Life Raft Inflation Cylinder, P/N
41918001, that had been installed on a Eurocopter AS 332 L2
helicopter. The plunger tube end is fitted with a metal end-fitting
that presses against the internal surface of the cylinder due to its
installation horizontally aboard the aircraft. Vibrations generated
by helicopter operation are therefore causing such wear, which may
result in a drop of internal pressure of the cylinder. This internal
damage, if not corrected, could lead to functional failure of the
cylinder, making the life raft inflation no longer possible.
    Pending the development of a modification to the inflation
cylinder, this AD requires identification of all affected cylinders
and the removal from service of those that have accumulated 2,500
Flight Hours (FH) or more since installation or since overhaul.

Actions and Compliance

    (e) Unless already done, do the following actions.
    (1) Within the next 100 hours time-in-service (TIS) after the
effective date of this AD, remove each life raft inflation cylinder,
P/N 41918001, that has accumulated or exceeded 2,500 hours TIS since
first installation or since last overhaul, whichever is later, in
accordance with Appendix 1, paragraph 3.1., of Eurocopter Alert
Service Bulletin No. 05.00.71, dated July 31, 2007 (ASB), and
replace it with an airworthy cylinder in accordance with Appendix 1,
paragraph 3.2 of the ASB.
    (2) After the effective date of this AD, no person shall install
a life raft inflation cylinder, P/N 41918001, on a helicopter, if
that cylinder has accumulated or exceeded 2,500 hours TIS since
first installation or since last overhaul, or if it is older than 3
years since manufacture and has never been overhauled.

Differences Between the FAA AD and the MCAI

    (f) This AD does not apply to Model EC 225 LP helicopters as
does the MCAI because that model helicopter is not type certificated
in the United States. Additionally, we have changed ``flight hours''
to ``hours time-in-service.'' We also clarified the applicable
paragraphs from the ASB in paragraph (e)(1) of this AD.

Subject

    (g) Air Transport Association of America (ATA) Code 2564: Life
Raft.

Other Information

    (h) The following provisions also apply to this AD:
    (1) Alternative Methods of Compliance (AMOCs): The Manager,
Safety Management Group, FAA, has the authority to approve AMOCs for
this AD, if requested using the procedures found in 14 CFR 39.19.
Send information to ATTN: Uday Garadi, Aviation Safety Engineer,
FAA, Rotorcraft Directorate, Regulations and Policy Group, Fort
Worth, Texas 76193-0110, telephone<PHONE_NUMBER>, fax (817) 222-
5961.
    (2) Airworthy Product: Use only FAA-approved corrective actions.
Corrective actions are considered FAA-approved if they are approved
by the State of Design Authority (or their delegated agent) if the
State of Design has an appropriate bilateral agreement with the
United States. You are required to assure the product is airworthy
before it is returned to service.
    (3) Reporting Requirements: For any reporting requirement in
this AD, under the provisions of the Paperwork Reduction Act, the
Office of Management and Budget (OMB) has approved the information
collection requirements and has assigned OMB Control Number 2120-
0056.

Related Information

    (i) Mandatory Continuing Airworthiness Information (MCAI) EASA
Airworthiness Directive 2007-0244, dated September 4, 2007 contains
related information.

Material Incorporated by Reference

    (j) The Director of the Federal Register approved the
incorporation by reference of Eurocopter Alert Service Bulletin No.
05.00.71, dated July 31, 2007, under 5 U.S.C. 552(a) and 1 CFR part
51.
    (k) For service information identified in this AD, contact
American Eurocopter Corporation, 2701 Forum Drive, Grand Prairie,
Texas 75053-4005, telephone<PHONE_NUMBER>, fax<PHONE_NUMBER>.
    (l) You may review copies of Eurocopter Alert Service Bulletin
No. 05.00.71, dated July 31, 2007, at the FAA, Office of the
Regional Counsel, Southwest Region, 2601 Meacham Blvd., Room 663,
Fort Worth, Texas or at the National Archives and Records
Administration (NARA). For information on the availability of this
material at NARA, call<PHONE_NUMBER>, or go to: http://www.archives.gov/federal-register/cfr/ibr-locations.html
.

    Issued in Fort Worth, Texas on January 23, 2008.
Scott A. Horn,
Acting Manager, Rotorcraft Directorate, Aircraft Certification Service.
 [FR Doc. E8-1701 Filed 2-4-08; 8:45 am]

BILLING CODE 4910-13-P


[Federal Register: September 29, 2006 (Volume 71, Number 189)]
[Notices]
[Page 57494-57495]
[DOCID:fr29se06-64]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket Nos. CP06-458-000]

Natural Gas Pipeline Company of America; Notice of Application

September 25, 2006.
    Take notice that on September 14, 2006, Natural Gas Pipeline
Company of America (Natural), 747 East 22nd Street, Lombard, Illinois
60148, filed in Docket No. CP06-458-000 an application pursuant to
sections 7 (b) and (c) of the Natural Gas Act (NGA) and Part 157 of the
Commission's Regulations, for:
    (1) Permission and approval to abandon Natural's lease (and
operation) of certain transmission facilities from The Peoples Gas
Light and Coke Company (PGLC) in the City of Chicago (City), Illinois;
    (2) Permission and approval to abandon, by sale to PGLC, certain
minor facilities in the City owned by Natural located along PGLC owned
facilities that will no longer be subject to lease by Natural; and
    (3) Certificate authorization to acquire by lease (and to operate)
certain transmission facilities from PGLC in the City pursuant to a new
lease agreement between PGLC and Natural.
    This application is on file with the Commission and open to public
inspection. This filing is accessible on-line at http://www.ferc.gov,

using the ``eLibrary'' link and is available for review in the
Commission's Public Reference Room in Washington, DC. There is an
``eSubscription'' link on the Web site that enables subscribers to
receive e-mail notification when a document is added to a subscribed
docket(s). For assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.
    Natural states that pursuant to lease agreements between Natural
and PGLC dated July 10, 1947, February 20, 1950 and July 16, 1970, as
amended April 20, 1976, Natural currently leases PGLC's Crawford Line
Nos. 1, 2 and 3 and Calumet Line Nos. 1, 2 and 3 within the City.
Natural further states it has executed a new lease agreement with PGLC
dated April 5, 2006 that will replace the old lease agreements and
which provides for an extension of term and a reduction of the leased
property in the Calumet Area (the lease of property in the Crawford
Area is to remain unchanged).
    The new lease arrangement in the City will continue to provide
Natural supervision, operation and control of facilities used by
Natural to make deliveries to PGLC, Nicor Gas and Northern Indiana
Public Service Company, three of Natural's largest transportation and
storage customers. The new lease arrangement does not include PGLC's
Calumet Line No. 3, which was removed to reflect PGLC's desire to
control and operate that pipeline as part of its local distribution
system in order to receive the supply of gas to be delivered to PGLC by
Kinder Morgan Illinois (KMIP), a new interstate natural gas pipeline
company (and Natural), at a new city gate station to be located near
138th Street and Torrence Avenue, which Natural is to construct, own
and operate under its blanket certificate. KMIP and Natural are filing
concurrently two related applications which involve KMIP constructing a
new pipeline system (KMIP Project), including the long term lease of
capacity from Natural,\1\ and Natural abandoning by lease to KMIP
certain capacity in existing pipelines owned by Natural.\2\
---------------------------------------------------------------------------

    \1\ KMIP is filing concurrently in Docket Nos. CP06-455-000, et
al. a related application seeking the above authority.
    \2\ Natural is filing concurrently in Docket No. CP06-454-000 a
related application seeking the above authority.
---------------------------------------------------------------------------

    Natural seeks this abandonment/certificate authority to coincide
with the abandonment and certificate authority requested by Natural and
KMIP in the two related applications.
    Any questions regarding this application should be directed to
Bruce H. Newsome, Vice President, Natural Gas Pipeline Company of
America, 747 East 22nd Street, Lombard, Illinois 60148 at (603) 691-
3526.
    There are two ways to become involved in the Commission's review of
this project. First, any person wishing to obtain legal status by
becoming a party to the proceedings for this project should, on or
before the comment date stated below, file with the Federal Energy
Regulatory Commission, 888 First Street, NE., Washington, DC 20426, a
motion to intervene in accordance with the requirements of the
Commission's Rules of Practice and Procedure (18 CFR 385.214 or
385.211) and the Regulations under the NGA (18 CFR 157.10). A person
obtaining party status will be placed on the service list maintained by
the Secretary of the Commission and will receive copies of all
documents filed by the applicant and by all other parties. A party must
submit 14 copies of filings made with the Commission and must mail a
copy to the applicant and to every other party in the proceeding. Only
parties to the proceeding can ask for court review of Commission orders
in the proceeding.
    However, a person does not have to intervene in order to have
comments considered. The second way to participate is by filing with
the Secretary of the Commission, as soon as possible, an original and
two copies of comments in support of or in opposition to this project.
The Commission will consider these comments in determining the
appropriate action to be taken, but the filing of a comment alone will
not serve to make the filer a party to the proceeding. The Commission's
rules require that persons filing comments in opposition to the project
provide copies of their protests only to the party or parties directly
involved in the protest.
    Persons who wish to comment only on the environmental review of
this project should submit an original and two copies of their comments
to the Secretary of the Commission. Environmental commentors will be
placed on the Commission's environmental mailing list, will receive
copies of the environmental documents, and will be notified of meetings
associated with the Commission's environmental review process.
Environmental commentors will not be required to serve copies of filed
documents on all other parties. However, the non-party commentors will
not receive copies of all documents filed by other parties or issued by
the Commission (except for the mailing of environmental documents
issued by the Commission) and will not have the right to seek court
review of the Commission's final order.
    Comments, protests and interventions may be filed electronically
via the Internet in lieu of paper. See 18 CFR 385.2001(a) (1) (iii) and
the instructions on the Commission's Web site under the

``e-Filing'' link at http://www.ferc.gov. The Commission strongly

encourages intervenors to file electronically. Persons unable to file
electronically should submit an original and 14 copies of the protest
or intervention to the Federal Energy Regulatory Commission, 888 First
Street, NE., Washington, DC 20426.
    Comment Date: October 16, 2006.

Magalie R. Salas,
Secretary.
[FR Doc. E6-16005 Filed 9-28-06; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 87, Number 109 (Tuesday, June 7, 2022)]
[Rules and Regulations]
[Pages 34573-34574]
[FR Doc No: 2022-12141]

========================================================================
Rules and Regulations
                                                Federal Register
________________________________________________________________________

This section of the FEDERAL REGISTER contains regulatory documents
having general applicability and legal effect, most of which are keyed
to and codified in the Code of Federal Regulations, which is published
under 50 titles pursuant to 44 U.S.C. 1510.

The Code of Federal Regulations is sold by the Superintendent of Documents.

========================================================================

Federal Register / Vol. 87, No. 109 / Tuesday, June 7, 2022 / Rules
and Regulations

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 71

[Docket No.FAA-2022-0267; Airspace Docket No. 22-ASO-4]
RIN 2120-AA66

Revocation of Class E Airspace; Winfield, FL

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This action removes Class E airspace in Winfield, FL, as I-10
Helistop Heliport has been abandoned and controlled airspace is no
longer required. This action enhances the safety and management of
controlled airspace within the national airspace system.

DATES: Effective 0901 UTC, September 8, 2022. The Director of the
Federal Register approves this incorporation by reference action under
1 CFR part 51, subject to the annual revision of FAA Order JO 7400.11
and publication of conforming amendments.

ADDRESSES: FAA Order JO 7400.11F, Airspace Designations and Reporting
Points, and subsequent amendments can be viewed online at https://www.faa.gov/air_traffic/publications/. For further information, you can
contact the Airspace Policy Group, Federal Aviation Administration, 800
Independence Avenue SW, Washington, DC 20591; Telephone: (202) 267-
8783.

FOR FURTHER INFORMATION CONTACT:  John Fornito, Operations Support
Group, Eastern Service Center, Federal Aviation Administration, 1701
Columbia Avenue, College Park, GA 30337; Telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Authority for This Rulemaking

    The FAA's authority to issue rules regarding aviation safety is
found in Title 49 of the United States Code. Subtitle I, Section 106,
describes the authority of the FAA Administrator. Subtitle VII,
Aviation Programs, describes in more detail the scope of the agency's
authority. This rulemaking is promulgated under the authority described
in Subtitle VII, Part A, Subpart I, Section 40103. Under that section,
the FAA is charged with prescribing regulations to assign the use of
airspace necessary to ensure the safety of aircraft and the efficient
use of airspace. This regulation is within the scope of that authority
as it removes Class E airspace extending upward from 700 feet above the
surface at I-10 Helistop Heliport, Winfield, FL, due to the closing of
the heliport.

History

    The FAA published a notice of proposed rulemaking in the Federal
Register (87 FR 19412, April 4, 2022) for Docket No. FAA-2022-0267 to
remove Class E airspace extending upward from 700 feet above the
surface at I-10 Helistop Heliport, Winfield, FL.
    Interested parties were invited to participate in this rulemaking
effort by submitting written comments on the proposal to the FAA. No
comments were received.
    Class E airspace designations are published in Paragraph 6005 of
FAA Order JO 7400.11F, dated August 10, 2021, and effective September
15, 2021, which is incorporated by reference in 14 CFR 71.1. The Class
E airspace designations listed in this document will be published
subsequently in FAA Order JO 7400.11.

Availability and Summary of Documents for Incorporation by Reference

    This document amends FAA Order JO 7400.11F, Airspace Designations
and Reporting Points, dated August 10, 2021, and effective September
15, 2021. FAA Order JO 7400.11F is publicly available as listed in the
ADDRESSES section of this document. FAA Order JO 7400.11F lists Class
A, B, C, D, and E airspace areas, air traffic routes, and reporting
points.

The Rule

    The FAA is amending 14 CFR part 71 by removing Class E airspace
extending upward from 700 feet above the surface at I-10 Helistop
Heliport, Winfield, FL, as the heliport has closed. Therefore, the
airspace is no longer necessary. This action enhances the safety and
management of controlled airspace within the national airspace system.
    Class E airspace designations are published in Paragraph 6005 of
FAA Order JO 7400.11F, dated August 10, 2021, and effective September
15, 2021, which is incorporated by reference in 14 CFR 71.1. The Class
E airspace designations listed in this document will be published
subsequently in the FAA Order JO 7400.11.
    FAA Order JO 7400.11, Airspace Designations and Reporting Points,
is published yearly and effective on September 15.

Regulatory Notices and Analyses

    The FAA has determined that this regulation only involves an
established body of technical regulations for which frequent and
routine amendments are necessary to keep them operationally current.
It, therefore: (1) is not a ``significant regulatory action'' under
Executive Order 12866; (2) is not a ``significant rule'' under DOT
Regulatory Policies and Procedures (44 FR 11034; February 26, 1979);
and (3) does not warrant preparation of a regulatory evaluation as the
anticipated impact is minimal. Since this is a routine matter that only
affects air traffic procedures and air navigation, it is certified that
this rule, when promulgated, does not have a significant economic
impact on a substantial number of small entities under the criteria of
the Regulatory Flexibility Act.

Environmental Review

    The FAA has determined that this action qualifies for categorical
exclusion under the National Environmental Policy Act in accordance
with FAA Order 1050.1F, ``Environmental Impacts: Policies and
Procedures,'' paragraph 5-6.5a. This airspace action is not expected to
cause any potentially significant environmental impacts, and no
extraordinary circumstances exist that warrant preparation of an
environmental assessment.

Lists of Subjects in 14 CFR Part 71

    Airspace, Incorporation by reference, Navigation (air).

Adoption of the Amendment

    In consideration of the foregoing, the Federal Aviation
Administration amends 14 CFR part 71 as follows:

PART 71--DESIGNATION OF CLASS A, B, C, D, AND E AIRSPACE AREAS; AIR
TRAFFIC SERVICE ROUTES; AND REPORTING POINTS

0
1. The authority citation for part 71 continues to read as follows:

    Authority:  49 U.S.C. 106(f), 106(g); 40103, 40113, 40120; E.O.
10854, 24 FR 9565, 3 CFR, 1959-1963 Comp., p. 389.

Sec.  71.1  [Amended]

0
2. The incorporation by reference in 14 CFR 71.1 of FAA Order 7400.11F,
Airspace Designations and Reporting Points, dated August 10, 2021, and
effective September 15, 2021, is amended as follows:

Paragraph 6005 Class E Airspace Areas Extending Upward From 700
Feet or More Above the Surface of the Earth.

* * * * *

ASO FL E5 Winfield, FL [Removed]

    Issued in College Park, Georgia, on June 1, 2022.
Andreese C. Davis,
Manager, Airspace & Procedures Team South, Eastern Service Center, Air
Traffic Organization.
[FR Doc. 2022-12141 Filed 6-6-22; 8:45 am]
BILLING CODE 4910-13-P


August 20, 2004 MEMORANDUM From: William H. Maxwell CG/ ESD ( C439 01)

To: Utility MACT Project Files Subject: Meeting with Electric Power Research Institute ( EPRI) and Charles River Associates ( CRA), August 20, 2004 Attendees EPRI/ CRA: Leonard Levin, EPRI ( by phone) John Novak, EPRI Anne Smith, CRA EPA: Tom Born, EPA/ OW/ OST Sharon Frey, EPA/ OW Paul Cocca, EPA/ OW/ OST Martin Schultz, EPA/ OW Ann Johnson, EPA/ OPEI Dan Axelrad, EPA/ OPEI Tamara Saltman, EPA/ OAR/ OAP Rita Schoeny, EPA/ OW Ellen Brown, EPA/ OAR/ OPAR Lisa Conner, EPA/ OAR/ OAQPS Rebecca Kauffman, ICF Consulting J. Renee Morin, ICF Consulting Peter Nagelhout, EPA/ OPEI/ NCEE Robert J. Wayland, EPA/ OAR/ OAQPS ( by phone) Dierdra Murphy, EPA/ OAR/ OAQPS ( by phone) Gail Lacy, EPA/ OAR/ OAQPS ( by phone) Randy Waite, EPA/ OAR/ OAQPS ( by phone) Larry Sorrels, EPA/ OAR/ OAQPS ( by phone) Tom Braverman, EPA/ OAR/ OAQPS ( by phone) Stan Durkee, EPA/ ORD ( by phone)

Discussion At the meeting, the separately docketed presentation materials were discussed.


[Federal Register Volume 82, Number 144 (Friday, July 28, 2017)]
[Notices]
[Page 35192]
[FR Doc No: 2017-15912]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #1

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER16-1923-000.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: Midcontinent Independent System Operator, Inc. submits
tariff filing per 35.19a(b): Refund Report (ER16-1923-000 and -002) to
be effective N/A.
    Filed Date: 7/21/17.
    Accession Number: 20170721-5120.
    Comments Due: 5 p.m. ET 8/11/17.

    Docket Numbers: ER17-2029-001.
    Applicants: Entergy Arkansas, Inc.
    Description: Tariff Amendment: EAI-ESI Reimbursement Agreement
Extension to be effective 12/31/9998.
    Filed Date: 7/20/17.
    Accession Number: 20170720-5136.
    Comments Due: 5 p.m. ET 8/10/17.

    Docket Numbers: ER17-2030-001.
    Applicants: Entergy Louisiana, LLC.
    Description: Tariff Amendment: ELL-ESI Reimbursement Agreement
Extemsion to be effective 12/31/9998.
    Filed Date: 7/20/17.
    Accession Number: 20170720-5138.
    Comments Due: 5 p.m. ET 8/10/17.

    Docket Numbers: ER17-2031-001.
    Applicants: Entergy Mississippi, Inc.
    Description: Tariff Amendment: EMI-ESI Reimbursement Agreement
Extension to be effective 12/31/9998.
    Filed Date: 7/20/17.
    Accession Number: 20170720-5139.
    Comments Due: 5 p.m. ET 8/10/17.

    Docket Numbers: ER17-2033-001.
    Applicants: Entergy New Orleans, Inc.
    Description: Tariff Amendment: ENO-ESI Reimbursement Agreement to
be effective 12/31/9998.
    Filed Date: 7/20/17.
    Accession Number: 20170720-5140.
    Comments Due: 5 p.m. ET 8/10/17.

    Docket Numbers: ER17-2034-001.
    Applicants: Entergy Texas, Inc.
    Description: Tariff Amendment: ETI-ESI Reimbursement Agreement to
be effective 12/31/9998.
    Filed Date: 7/20/17.
    Accession Number: 20170720-5141.
    Comments Due: 5 p.m. ET 8/10/17.

    Docket Numbers: ER17-2115-000.
    Applicants: Northern States Power Company, a Minnesota corporation.
    Description: Sec.  205(d) Rate Filing: NSPM Concurrence to OTP RS
110, Suppl No. 3 to be effective 4/16/2016.
    Filed Date: 7/21/17.
    Accession Number: 20170721-5001.
    Comments Due: 5 p.m. ET 8/11/17.

    Docket Numbers: ER17-2116-000.
    Applicants: Midcontinent Independent System Operator Inc., ITC
Midwest LLC.
    Description: Sec.  205(d) Rate Filing: 2017-07-21_Revisions to ITCM
Attachment O for Abandoned Plant Incentive to be effective 9/20/2017.
    Filed Date: 7/21/17.
    Accession Number: 20170721-5040.
    Comments Due: 5 p.m. ET 8/11/17.

    Docket Numbers: ER17-2118-000.
    Applicants: ISO New England Inc., New England Power Pool
Participants Comm.
    Description: Sec.  205(d) Rate Filing: Rev. to Sec. II.44(1)(a) to
Conform with Day-Ahead Energy Mkt. Sched. Timeline to be effective 9/
20/2017.
    Filed Date: 7/21/17.
    Accession Number: 20170721-5092.
    Comments Due: 5 p.m. ET 8/11/17.

    Docket Numbers: ER17-2119-000.
    Applicants: Energy Consulting Services, LLC.
    Description: Notice of cancellation of Market-Based Rate Tariff of
Energy Consulting Services, LLC.
    Filed Date: 7/19/17.
    Accession Number: 20170720-0015.
    Comments Due: 5 p.m. ET 8/9/17.

    Take notice that the Commission received the following foreign
utility company status filings:

    Docket Numbers: FC17-4-000.
    Applicants: I Squared Capital.
    Description: Self-Certification of FUCO on behalf of Orazul
Companies.
    Filed Date: 7/21/17.
    Accession Number: 20170721-5066.
    Comments Due: 5 p.m. ET 8/11/17.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: July 21, 2017.
Kimberly D. Bose,
Secretary.
[FR Doc. 2017-15912 Filed 7-27-17; 8:45 am]
 BILLING CODE 6717-01-P


Comment Info: =================

General Comment:A 75 day period time to review the proposed regulations is insufficient.  I request that the review period be extended to 180 days